The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Hemodynamic and Functional Assessment of Patients with Sickle Cell Disease and Pulmonary Hypertension
Open accessAbstract
RATIONALE: Although pulmonary hypertension (PH) is a common complication of sickle cell disease (SCD) associated with high mortality, there exist few data characterizing hemodynamics and cardiopulmonary function in this population. OBJECTIVES: To characterize hemodynamics and cardiopulmonary function in patients with SCD with and without PH. METHODS: Patients with SCD with PH (n = 26) were compared with control subjects with SCD but without PH (n = 17), matched for age, hemoglobin levels, and fetal hemoglobin levels. MEASUREMENTS AND MAIN RESULTS: Upon catheterization, 54% of the patients with PH had pulmonary arterial hypertension, and 46% had pulmonary venous hypertension. When compared with control subjects, patients with PH exhibited lower six-minute-walk distance (435 +/- 31 vs. 320 +/- 20 m, p = 0.002) and oxygen consumption (50 +/- 3% vs. 41 +/- 2% of predicted, p = 0.02), and also had mild restrictive lung disease and more perfusion abnormalities on radionuclide lung scans. The six-minute-walk distance in this population inversely correlated with tricuspid regurgitant jet velocity (r = -0.55, p < 0.001), and mean pulmonary artery pressure (r = -0.57, p < 0.001), and directly correlated with maximal oxygen consumption (r = 0.49, p = 0.004), even after adjustment for hemoglobin, supporting an independent contribution of increasing pulmonary artery pressures to loss of exercise capacity. CONCLUSIONS: Patients with SCD-associated PH have both pulmonary arterial and venous PH associated with severe limitations in exercise capacity, likely compounded by interstitial lung fibrosis and severe anemia. These data support the use of the six-minute-walk distance as an index of PH and cardiopulmonary function in patients with SCD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
Standardization of Spirometry, 1994 Update. American Thoracic Society.
(1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663792 · Cited by 6,594
ATS/ACCP statement on cardiopulmonary exercise testing
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.167.2.211 · Cited by 3,026
Bosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., Keogh, A., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,726
Self-citationPrinciples of Exercise Testing and Interpretation.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-4-646 · Cited by 2,359
Rother, R. P., Bell, L., Hillmen, P., & Gladwin, M. T. (2005) · JAMA · doi:10.1001/jama.293.13.1653 · Cited by 1,557
Self-citationThe Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,550
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Self-citationPredicted Values for Clinical Exercise Testing 1– 3
Hansen, J. E., Sue, D. Y., & Wasserman, K. (1984) · American Review of Respiratory Disease · doi:10.1164/arrd.1984.129.2p2.s49 · Cited by 929
Morris, C. R. (2005) · JAMA · doi:10.1001/jama.294.1.81 · Cited by 763
Berger, M., Haimowitz, A., Van Tosh, A., Berdoff, R. L., & Goldberg, E. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80172-8 · Cited by 742
Sitaxsentan Therapy for Pulmonary Arterial Hypertension
Barst, R. J., Langleben, D., Frost, A., Horn, E. M., Oudiz, R., Shapiro, S., McLaughlin, V., Hill, N., Tapson, V. F., Robbins, I. M., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200307-957oc · Cited by 706
Crapo, R. O., Hankinson, J., Irvin, C. G., et al. (1995) · American Journal of Respiratory and Critical Care Medicine · Cited by 593
(1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.6.8520796 · Cited by 490
Philippidis, P., Mason, J. C., Evans, B. J., Nadra, I., Taylor, K. M., Haskard, D. O., & Landis, R. C. (2004) · Circulation Research · doi:10.1161/01.res.0000109414.78907.f9 · Cited by 476
Mahapatra, S., Nishimura, R. A., Sorajja, P., Cha, S., & McGoon, M. D. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.054 · Cited by 416
ATS statement on six-minute walk test
Brooks, D., & Solway, S. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.167.9.950 · Cited by 352
Causes of death in sickle cell disease: an autopsy study
Manci, E. A., Culberson, D. E., Yang, Y., Gardner, T. M., Powell, R., Haynes, J., Shah, A. K., Mankad, V. N., & Investigators of the Cooperative Study of Sickle Cell Disease (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04594.x · Cited by 350
Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival
Castro, O., Hoque, M., & Brown, B. D. (2003) · Blood · doi:10.1182/blood-2002-03-0948 · Cited by 327
Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients With Sickle Cell Disease
Sachdev, V., Machado, R. F., Shizukuda, Y., Rao, Y. N., Sidenko, S., Ernst, I., St. Peter, M., Coles, W. A., Rosing, D. R., Blackwelder, W. C., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.038 · Cited by 323
Self-citationCardiac involvement in thalassemia intermedia: a multicenter study
Aessopos, A., Farmakis, D., Karagiorga, M., Voskaridou, E., Loutradi, A., Hatziliami, A., Joussef, J., Rombos, J., & Loukopoulos, D. (2001) · Blood · doi:10.1182/blood.v97.11.3411 · Cited by 298
Pulmonary function in primary pulmonary hypertension
Sun, X.-G., Hansen, J. E., Oudiz, R. J., & Wasserman, K. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02964-9 · Cited by 207
Pulmonary hypertension in sickle cell hemoglobinopathy: A clinicopathologic study of 20 cases
Haque, A. K., Gokhale, S., Rampy, B. A., Adegboyega, P., Duarte, A., & Saldana, M. J. (2002) · Human Pathology · doi:10.1053/hupa.2002.128059 · Cited by 202
N-Terminal Pro-Brain Natriuretic Peptide Levels and Risk of Death in Sickle Cell Disease
Machado, R. F., Anthi, A., Steinberg, M. H., Bonds, D., Sachdev, V., Kato, G. J., Taveira-DaSilva, A. M., Ballas, S. K., Blackwelder, W., Xu, X., et al. (2006) · JAMA · doi:10.1001/jama.296.3.310 · Cited by 197
Self-citationMachado, R. F., & Gladwin, M. T. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05432.x · Cited by 160
Self-citationPulmonary Thrombotic Arteriopathy in Patients With Sickle Cell Disease
Adedeji, M. O., Cespedes, J., Allen, K. G., Subramony, C., & Hughson, M. D. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-1436-ptaipw · Cited by 156
Hemodynamic Effects of Chronic Severe Anemia
Roy, S. B., Bhatia, M. L., Mathur, V. S., & Virmani, S. (1963) · Circulation · doi:10.1161/01.cir.28.3.346 · Cited by 107
Pulmonary Complications of Sickle Cell Anemia
Minter, K. R., & Gladwin, M. T. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.11.2104101 · Cited by 102
Self-citationPulmonary Hypertension in Sickle Cell Disease
Vichinsky, E. P. (2004) · New England Journal of Medicine · doi:10.1056/nejmp038250 · Cited by 101
Maximal Oxygen Uptake and Severity of Disease in Lymphangioleiomyomatosis
Taveira‐DaSilva, A. M., Stylianou, M. P., Hedin, C. J., Kristof, A. S., Avila, N. A., Rabel, A., Travis, W. D., & Moss, J. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200206-593oc · Cited by 97
Self-citationHemodynamic Studies in Sickle Cell Anemia
Leight, L., Snider, T. H., Clifford, G. O., & Hellems, H. K. (1954) · Circulation · doi:10.1161/01.cir.10.5.653 · Cited by 92
de Cleva, R., Herman, P., Pugliese, V., Zilberstein, B., Saad, W. A., Rodrigues, J. J. G., & Laudanna, A. A. (2003) · PubMed · Cited by 78
Successful Pulmonary Thromboendarterectomy in Two Patients with Sickle Cell Disease
Yung, G., Channick, R. N., Fedullo, P. F., Auger, W. R., Kerr, K. M., Jamieson, S. W., Kapelanski, D. P., & Moser, K. Μ. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9710032 · Cited by 65
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Klings, E. S., & Farber, H. W. (2004) · New England Journal of Medicine · doi:10.1056/nejm200406103502418 · Cited by 64
Cited by
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citationACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R., Mathier, M. A., McGoon, M. D., Park, M. H., Rosenson, R. S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.004 · Cited by 2,360
Self-citationUpdated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Self-citationWriting Committee Members, McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R., Mathier, M. A., McGoon, M. D., Park, M. H., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192230 · Cited by 1,093
Self-citationIntravascular hemolysis and the pathophysiology of sickle cell disease
Kato, G. J., Steinberg, M. H., & Gladwin, M. T. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89741 · Cited by 748
“TRV ≥ 2.5 m/s also predicts a higher risk of leg ulcers (46, 60), thrombosis (58), proteinuria (60, 73), and exercise intolerance (74, 75), suggesting that it also serves as a marker for more general vasculopathy.”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Anthi, A., Machado, R. F., Jison, M. L., Taveira-DaSilva, A. M., Rubin, L. J., Hunter, L., Hunter, C. J., Coles, W., Nichols, J., Avila, N. A., Sachdev, V., Chen, C. C., & Gladwin, M. T.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-06-15
- Volume
- 175
- Issue
- 12
- Pages
- 1272-1279
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2115487496
- Cited by
- 270
- References
- 34
- FWCI
- 9.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.